How much do paid clinical trials in Spokane pay?

Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.

Do I need to be sick to join a clinical trial in Spokane?

No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.

Are clinical trials in Spokane safe?

Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.

How do I join a study in Spokane, WA?

Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.

How often do new paid studies open in Spokane?

Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Spokane.

Paid Clinical Trials Spokane, WA — 291 Studies Recruiting (Oct 2026)

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought

Cancer Care Northwest - Spokane South — Spokane, Washington (0.5 mi) · Sponsor: SWOG Cancer Research Network

See eligibility & contact on ClinicalTrials.gov (NCT03851445)

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer, c-MET Phase 3 Interventional 768 participants sought

Medical Oncology Associates /ID# 247003 — Spokane, Washington (0.5 mi) · Sponsor: AbbVie

See eligibility & contact on ClinicalTrials.gov (NCT04928846)

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Breast Neoplasms, Triple Negative Breast Neoplasms Phase 3 Interventional 2,400 participants sought

Cancer Care Northwest ( Site 0003) — Spokane, Washington (0.5 mi) · Sponsor: Merck Sharp & Dohme LLC

See eligibility & contact on ClinicalTrials.gov (NCT06966700)

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Urothelial Cancer, Bladder Cancer Phase 2, Phase 3 Interventional 630 participants sought

Research Site — Spokane, Washington (0.5 mi) · Sponsor: Daiichi Sankyo

See eligibility & contact on ClinicalTrials.gov (NCT07129993)

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

Non-Small Cell Lung Cancer (NSCLC) Phase 3 Interventional 750 participants sought

Local Institution - 0384 — Spokane, Washington (0.5 mi) · Sponsor: Bristol-Myers Squibb

See eligibility & contact on ClinicalTrials.gov (NCT07361510)

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

Childhood Medulloblastoma Phase 3 Interventional 225 participants sought

Providence Sacred Heart Medical Center and Children's Hospital — Spokane, Washington (0.5 mi) · Sponsor: Children's Oncology Group

See eligibility & contact on ClinicalTrials.gov (NCT05382338)

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

Locally Advanced Head and Neck Squamous Cell Carcinoma Phase 3 Interventional 1,145 participants sought

Research Site — Spokane, Washington (0.5 mi) · Sponsor: AstraZeneca

See eligibility & contact on ClinicalTrials.gov (NCT06129864)

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

Systemic Lupus Erythematosus Phase 3 Interventional 450 participants sought

Sl0044 50061 — Spokane Valley, Washington (9.0 mi) · Sponsor: UCB Biopharma SRL

See eligibility & contact on ClinicalTrials.gov (NCT06617325)

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought

Ohio State University Telemedicine — Spokane, Washington (0.5 mi) · Sponsor: Sameek Roychowdhury

See eligibility & contact on ClinicalTrials.gov (NCT06906562)

A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy

PARKINSON DISEASE (Disorder) Phase 2 Interventional 80 participants sought

Vima Site #015 — Spokane, Washington (0.5 mi) · Sponsor: Vima Therapeutics

See eligibility & contact on ClinicalTrials.gov (NCT07804615)

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Smoldering Plasma Cell Myeloma Phase 3 Interventional 288 participants sought

Cancer Care Northwest - Spokane South — Spokane, Washington (0.5 mi) · Sponsor: ECOG-ACRIN Cancer Research Group

See eligibility & contact on ClinicalTrials.gov (NCT03937635)

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

Heart Failure, Acute Heart Failure Phase 3 Interventional 5,200 participants sought

Spokane, WA Investigative Site 10123 — Spokane, Washington (0.5 mi) · Sponsor: Colorado Prevention Center

See eligibility & contact on ClinicalTrials.gov (NCT06008197)

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

Lung Non-Small Cell Carcinoma Phase 3 Interventional 336 participants sought

Kootenai Clinic Cancer Services - Post Falls — Post Falls, Idaho (22.7 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT07388524)

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Breast Cancer Phase 3 Interventional 3,960 participants sought

Cancer Care Northwest - Spokane South — Spokane, Washington (0.5 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT05879926)

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

Breast Cancer, TNBC - Triple-Negative Breast Cancer N/A Observational 900 participants sought

Cancer Care Northwest — Spokane Valley, Washington (9.0 mi) · Sponsor: Tempus AI

See eligibility & contact on ClinicalTrials.gov (NCT07211178)

C-Brace Prospective Registry

Pareses, Lower Extremity N/A Observational 250 participants sought

Thompson's O&P — Spokane, Washington (0.5 mi) · Sponsor: Otto Bock Healthcare Products GmbH

See eligibility & contact on ClinicalTrials.gov (NCT04640584)

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

Diabetic Nephropathies, Kidney Failure, Chronic Phase 3 Interventional 150 participants sought

Providence Sacred Heart Medical Center — Spokane, Washington (0.5 mi) · Sponsor: Alessandro Doria

See eligibility & contact on ClinicalTrials.gov (NCT06217302)

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines

Psoriatic Arthritis Phase 3 Interventional 1,088 participants sought

Arthritis Northwest, PLLC | Spokane, WA — Spokane, Washington (0.5 mi) · Sponsor: Takeda

See eligibility & contact on ClinicalTrials.gov (NCT06671483)

ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL

CLL / SLL, CLL (Chronic Lymphocytic Leukemia) Phase 3 Interventional 306 participants sought

Medical Oncology Associates - Spokane — Spokane, Washington (0.5 mi) · Sponsor: Newave Pharmaceutical Inc

See eligibility & contact on ClinicalTrials.gov (NCT07342478)

Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy

Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma, Recurrent Platinum-Sensitive Fallopian Tube High Grade Serous Adenocarcinoma Phase 2 Interventional 87 participants sought

Kootenai Clinic Cancer Services - Post Falls — Post Falls, Idaho (22.7 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT07504588)

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

Mitral Valve Regurgitation N/A Interventional 1,056 participants sought

Providence Sacred Heart Medical Center & Children's Hospital — Spokane, Washington (0.5 mi) · Sponsor: Medtronic Cardiovascular

See eligibility & contact on ClinicalTrials.gov (NCT03242642)

A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

Low Grade Astrocytoma, Low Grade Glioma Phase 3 Interventional 170 participants sought

Providence Sacred Heart Medical Center and Children's Hospital — Spokane, Washington (0.5 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT04166409)

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Phase 3 Interventional 247 participants sought

Kootenai Clinic Cancer Services - Post Falls — Post Falls, Idaho (22.7 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT04269902)

An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy

Multiple System Atrophy Phase 2 Interventional 200 participants sought

Teva Investigational Site 15543 — Spokane, Washington (0.5 mi) · Sponsor: Teva Branded Pharmaceutical Products R&D LLC

See eligibility & contact on ClinicalTrials.gov (NCT07197866)

A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

Hypothyroidism Phase 2, Phase 3 Interventional 2,800 participants sought

MultiCare Rockwood Clinic /ID# 255951 — Spokane, Washington (0.5 mi) · Sponsor: AbbVie

See eligibility & contact on ClinicalTrials.gov (NCT06345339)

Paid Clinical Trials in Spokane, WA

Studies recruiting near Spokane right now

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

C-Brace Prospective Registry

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines

ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL

Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy

A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

Studies you may be able to join near Spokane

See which clinical studies you may qualify for

Top-rated research centers in Spokane

Inland Northwest Research

Premier Clinical Research

Providence Medical Research Center

Citta Clinical Research

Principle Research Solutions

WSU Spokane Center for Clinical Research and Simulation (CCRS)

WSU APPL & PRISM Research Clinics

Strategic Research Associates

Velocity Clinical Research

Clinical trials in Spokane: what's recruiting

How to enroll in a paid study in Spokane

Frequently asked questions

Paid clinical trials near Spokane

By condition

More of WA

New paid studies open every week